They say imitation is the best form of flattery. In announcing that it was buying Chinese orthopedics company Trauson Holdings Company Limited, Kalamazoo, Michigan-based Stryker (NYSE:SYK) is following in the footsteps of medical device heavy weight Medtronic. Barely four months ago, the Minnesota medical device maker announced that it was buying Kanghui Holdings, which described […]
The 75 direct sales force dedicated to boost Stryker’s (NYSE: SYK) foot and ankle business unit had a stellar year in 2012, said CEO Kevin Lobo, to a packed room at the J.P. Morgan Healthcare Conference in San Francisco on Wednesday. The unit had a 40 percent increase in U.S. sales in the fourth quarter. “If […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Just one month ago, Kevin Lobo took over the top spot at medical device maker Stryker Corp. (NYSE:SYK) On Monday, he explained the $8.5 billion corporation’s innovation strategy moving forward in his first public appearance as CEO at Cleveland Clinic’s Medical Innovation Summit. Formerly president of J&J company Ethicon Endo-Surgery and then head of Stryker’s […]
Stryker announced Monday that the U.S. Food and Drug Administration has cleared a clot removal device to treat patients experiencing acute ischemic stroke. Ischemic strokes are caused by blocked arteries and constitute the overwhelming majority of strokes, according to the Mayo Clinic. The Trevo Pro Retrieval System performed better than Merci Retrieval, made by Concentric […]
Synthes is back in court, this time as the plaintiff in a lawsuit against Stryker Corp. (NYSE: SYK) accusing the Michigan-based medical device company of trying to obtain “an improper competitive advantage.” The complaint, filed in federal court in Philadelphia, also singled out three former sales staff from Synthes’ San Francisco sales unit who resigned from […]
Stryker Corp.’s (NYSE:SYK) second-quarter sales slid more than 3 percent, despite a top-line rise of 16.3 percent, as the Kalamazoo, Mich.-based medical device maker digested a pair of big acquisitions. Stryker posted earnings of $309 million, or 79 cents per diluted share, on sales of $2.05 billion during the three months ended June 30. That […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Stryker Corp. (NYSE:SYK) inked new deals for its joint preservation arm and its interventional spine division this week. The Kalamazoo, Mich.-based company added its inflatable vertebral augmentation system (iVAS) to its national agreement with supply contracting company Novation LLC. The deal makes Stryker the single source for balloon-assisted spine augmentation for health care groups UHC, […]
Stryker Corp. (NYSE:SYK) is fielding legal challenges on two fronts, one from a former distributor and DePuy Spine and another from a Utah man claiming a Stryker pain pump destroyed his shoulder. DePuy and BioInitiatives Inc., a former Stryker Spine distributor, asked a California judge for an injunction barring Stryker from enforcing a non-competition clause […]
Michael Mogul, the head of Stryker Corp.’s (NYSE:SYK) $4-billion-plus orthopedics division, is off to greener pastures: The corner office at DJO Global Inc. Mogul, 46, was with Stryker for most of his professional life. He joined the Kalamazoo, Mich.-based medical device giant in 1989 when he was just 24 years old and worked his way […]
Shareholders of Orthovita Inc. (NSDQ: VITA), a Malvern, Pa.-based orthopedic biologics maker, are suing over a proposed $316 million merger by Stryker Corp. (NYSE:SYK ) that represents a hefty percent premium on VITA stock price. The stockholders, led by Andrew Thorn, accused the two companies and Orthovita’s board of breaching its fiduciary duty in agreeing […]
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Stryker Corp. (NYSE: SYK ) CEO Stephen MacMillan took time out to tout his company’s resilience at an analyst meeting in New York Wednesday. MacMillan said the Kalamazoo, Mich.-based orthopedic and medical equipment giant has proven its mettle in tough times, something he said would allow it to continue to perform, despite struggles in the […]
Stryker Corp. CEO Stephen MacMillan ceded another pay raise last year, citing the “challenging business environment” and leaving the orthopedics giant’s top boss at 2008 base pay levels. Stryker Corp. (NYSE: SYK ) CEO Stephen MacMillan once again deferred a pay raise in 2010 due to the “challenging business environment,” despite increasing the company’s bottom […]
The Stryker lawsuit claims the company improperly promoted off-label use of a pair of bone-growth products and also lied to the Food & Drug Administration. Stryker Biotech now says the government is over-reaching with its indictment and failing to back up most of its charges.
Orthopedics company Stryker Corp. (NYSE:SYK) has agreed to sell a product line including the bone growth putty that has caused the company so much legal grief to Olympus Corp. for $60 million. Kalamazoo, Michigan-based Stryker plans to record a loss on the sale of its OP-1 product line of between $75 million and $80 million.
I've devoted plenty of Internet ink to the diverging fortunes of St. Jude Medical Inc. (NYSE:STJ) and Boston Scientific Corp. (NYSE:BSX). Apparently other people see the same thing.